Matarin Capital Management Portfolio holdings
Top Buys
| 1 |
REGI
Renewable Energy Group, Inc.
REGI
|
+$8.64M |
| 2 |
AMN Healthcare
AMN
|
+$7.28M |
| 3 |
AMWD
American Woodmark
AMWD
|
+$6.65M |
| 4 |
Mueller Industries
MLI
|
+$6.09M |
| 5 |
Emergent Biosolutions
EBS
|
+$5.7M |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
+$12.3M |
| 2 |
Insight Enterprises
NSIT
|
+$12.1M |
| 3 |
Apple
AAPL
|
+$10.3M |
| 4 |
SAFM
Sanderson Farms Inc
SAFM
|
+$8.42M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
+$8.41M |
Sector Composition
| 1 | Financials | 16.05% |
| 2 | Healthcare | 15.51% |
| 3 | Technology | 15.03% |
| 4 | Industrials | 13.43% |
| 5 | Consumer Discretionary | 12.72% |
Similar funds
Matarin Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Matarin Capital Management held 265 positions worth $644M, down 38% from $1.05B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management withdrew a net $94M in Q1 2020, closing 67 positions and reducing 108 holdings. Its most notable exit was Arrowhead Research, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Matarin Capital Management opened a new position in Renewable Energy Group, Inc. worth $7.01M.
- Matarin Capital Management's largest Q1 2020 buy was Renewable Energy Group, Inc.: 341,327 shares worth $7.01M.
- Matarin Capital Management added most to AMN Healthcare in Q1 2020, an estimated $7.28M increase.
- Matarin Capital Management's biggest Q1 2020 reduction was Apple, cutting an estimated $10.3M.
- Matarin Capital Management fully exited Arrowhead Research in Q1 2020, selling an estimated $12.3M.
- Matarin Capital Management's ten largest holdings make up 13% of its $644M portfolio in Q1 2020.
- Matarin Capital Management opened 30 new positions and closed 67 in Q1 2020.
- Matarin Capital Management's portfolio value fell 38% quarter-over-quarter to $644M.
Based on Matarin Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.